0001209191-20-060730.txt : 20201130 0001209191-20-060730.hdr.sgml : 20201130 20201130161739 ACCESSION NUMBER: 0001209191-20-060730 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201125 FILED AS OF DATE: 20201130 DATE AS OF CHANGE: 20201130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schor Chen CENTRAL INDEX KEY: 0001340875 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36167 FILM NUMBER: 201358325 MAIL ADDRESS: STREET 1: PREDIX PHARMACEUTICALS HOLDINGS, INC. STREET 2: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc. CENTRAL INDEX KEY: 0001503802 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263931704 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 BUSINESS PHONE: 617-658-0600 MAIL ADDRESS: STREET 1: 85 WELLS AVENUE STREET 2: SECOND FLOOR CITY: NEWTON STATE: MA ZIP: 02459 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-25 0 0001503802 Karyopharm Therapeutics Inc. KPTI 0001340875 Schor Chen C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE NEWTON MA 02459 1 0 0 0 Nonstatutory Stock Option (right to buy) 14.75 2020-11-25 4 A 0 32800 0.00 A 2030-11-24 Common Stock 32800 32800 D This option was granted on November 25, 2020. The shares underlying this option vest as to one-third (1/3) of the shares on November 25, 2021 and as to the remaining two-thirds (2/3) of the shares in 24 equal monthly installments thereafter. /s/ Christopher B. Primiano, Attorney-in-Fact for Chen Schor 2020-11-30